LEAD and the Next Phase of Accountable Care

Back to Resources
ATI – Insights
02/26/2026
AUTHOR – ATI Advisory

The CMS Innovation Center’s recent communications on the Long-term Enhanced ACO Design (LEAD) Model offer some of the clearest signals yet about where accountable care is heading. For organizations experienced in ACO REACH or the Medicare Shared Savings Program (MSSP), LEAD is not simply a successor model. It reflects a structural convergence of lessons learned across programs, blending MSSP attribution mechanics, REACH risk experience, and a more standardized benchmarking framework. In doing so, CMS signals that accountable care has matured beyond experimentation into a more durable, system-wide risk architecture.

One of the most consequential shifts under LEAD is how the model approaches high-needs populations. Rather than carving out complexity into a standalone track, LEAD embeds high-needs beneficiaries across the attributed population, reshaping how ACOs will need to think about care delivery, attribution, and financial performance.

Raising the Bar on Managing High-Needs Populations

Under prior models, high-needs populations were often addressed through discrete eligibility pathways. LEAD moves away from that structure. Instead, beneficiaries with complex clinical, functional, and social needs are embedded across ACO populations and accounted for through differentiated risk adjustment and financial methodologies.

This shift matters because a substantial share of Medicare fee-for-service spending among complex beneficiaries remains outside accountable care arrangements today. Despite demonstrated success among LTC-focused ACOs, most long-term care beneficiaries are still unmanaged from an accountable care perspective, and fragmentation across multiple ACOs remains common even when alignment occurs.

LEAD’s design signals CMS’ broader intent to address fragmentation from a population-based approach. For ACOs, this shift changes operational expectations, with a greater emphasis on managing complexity across the full attributed population rather than within distinct high-needs programs.

Redefining “High Needs” Under LEAD

In practice, LEAD’s approach may broaden the concept of “high needs” beyond formal eligibility criteria. Under ACO REACH, High Needs ACOs have demonstrated strong performance, yet more than 30 percent of long-stay nursing facility residents fail to meet high-needs eligibility criteria in practice. The gap reflects structural factors — documentation challenges, dual eligibility dynamics, and institutional care patterns — that affect how residents are categorized. 

LEAD implicitly shifts the question from “Who qualifies?” to “How effectively can complexity be managed?” In this structure, clinical acuity, utilization patterns, and social risk factors are no longer confined to a separate track; they directly influence financial performance across the ACO’s entire population. 

For ACO leaders, this has implications for care model design, staffing, and analytics. Population segmentation, risk stratification, and care management approaches will need to accommodate a wider range of needs without relying on categorical exclusions.

Attribution and Alignment Flexibility

LEAD also introduces more flexible attribution and alignment mechanics, combining MSSP-like full TIN attribution with continued use of TIN/NPI combinations to support preferred provider relationships. Voluntary and claims-based alignment remain, with additional flexibility through mid-year TIN additions and monthly voluntary alignment updates.

These design choices are particularly relevant for high-needs populations, where attribution challenges often drive fragmentation. Today, many nursing facilities have multiple ACOs simultaneously managing Medicare spending for different residents, limiting accountability and complicating care coordination.

Under LEAD, attribution becomes less of a technical detail and more of a strategic capability. ACOs that actively manage alignment — particularly for complex and institutionalized beneficiaries — will be better positioned to reduce fragmentation and support more consistent care models.

A New Benchmarking and Risk Framework

LEAD’s benchmarking approach blends historical experience with a transition toward Medicare Advantage rate book references, without rebasing and without negative regional adjustments. Prior savings adjustments are maintained, signaling CMS’ intent to support long-term participation while tightening incentives over time.

This framework reflects broader CMS confidence that value-based care has matured beyond experimentation. Stricter benchmarking and risk adjustment rules across programs suggest a sustained focus on constraining total program spending. In practical terms, this means performance variance will matter more. Margin compression is likely for organizations relying heavily on coding intensity or favorable rebasing cycles. Under LEAD’s structure, sustainable performance will depend more directly on care redesign, specialty integration, and managing outcomes.

For organizations serving high-needs populations, these changes heighten the importance of disciplined financial modeling. Performance will be increasingly sensitive to coding practices, utilization management, and the ability to redesign care for complex beneficiaries within a more predictable financial structure.

Specialty Integration and Complex Care

LEAD further encourages specialty engagement through CMS-Administered Risk Arrangements (CARA), including “shadow bundles” that allow ACOs to test episode-based risk arrangements with CMS support. For high-needs populations, particularly those in long-term care settings, specialty utilization is often a key cost and quality driver.

By lowering administrative barriers and standardizing episode-based approaches, CARA creates new pathways for integrating specialty care into accountable care models. This aligns with evidence from physician-led and LTC-focused ACOs, where tighter primary and specialty care integration has been a consistent contributor to stronger performance.

What ACO Leaders Should Be Pressure-Testing Now

Taken together, LEAD’s design choices raise several questions that ACO leaders should be evaluating well ahead of the application window:

  • Are current care models equipped to manage high-needs beneficiaries embedded across the population, rather than in discrete programs?
  • Do attribution and alignment strategies reduce fragmentation, particularly in institutional and post-acute settings?
  • Are financial assumptions resilient under LEAD’s benchmarking and risk framework?
  • How prepared is the organization to integrate specialty care more systematically for complex patients?

Organizations with mature analytics infrastructure, active attribution management, and experience managing complex or institutional populations may find LEAD aligns naturally with existing capabilities. Conversely, ACOs heavily dependent on coding-driven performance or operating with limited care management integration may face a steeper transition under LEAD’s tighter benchmarking and embedded high-needs framework. The answers will vary by organization, but the need for earlier and more informed decision-making is clear.

How ATI Supports LEAD Readiness

As ACOs assess LEAD participation, readiness will hinge on aligning strategy, analytics, and operations with the model’s demands. ATI supports organizations by helping them pressure-test financial assumptions, refine attribution and alignment strategies, and design care models capable of managing embedded high-needs populations.

This includes analytic support for attribution and benchmarking, operational planning for complex care delivery, and strategic guidance for navigating uncertainty as CMS’ ACO portfolio continues to evolve. We go beyond optimizing for any single model by helping organizations build capabilities that are durable across the next phase of accountable care.

Looking Ahead

LEAD rewards organizations that understand accountable care deeply, from attribution mechanics and benchmark design to care transformation and specialty integration. How ACOs define, manage, and invest in high-needs populations will likely become one of the most important determinants of sustained performance under LEAD.

With application timelines approaching and design details coming into focus, now is the moment for ACO leaders to move from observation to preparation.


Note: This is Part 2 of ATI Advisory’s LEAD Readiness Series. Part 1 examined LEAD’s impact on high-needs and long-term care populations. Here, we assess what LEAD signals about the next phase of accountable care strategy and risk.

Recent Insights

Insights

For MSSP ACOs Serving High Needs Populations, LEAD Offers a Clear Path Forward

LEAD gives MSSP ACOs and health systems with deep value-based care experience a way to serve High Needs beneficiaries on payment terms that align with their acuity and changing care needs. Its benchmarks, risk adjustment, and monthly capitation features respond to structural challenges that established organizations have encountered in other models, aiming to generate lower utilization and total cost of care for High Needs beneficiaries while improving outcomes.
Read More Read More
Insights

Community-Based Care Models Offer Replicable Solutions Enabling Aging in Place

Community-based care models can help close the gap between what older adults can afford and the long-term care they need to stay in their homes. This joint AARP Public Policy Institute and ATI Advisory report offers a program replicability framework and three in-depth profiles, with practical lessons for state and local leaders working to sustain care options outside of Medicaid.
Read More Read More
Insights

Medicare Advantage Is Now a Central Financing Mechanism for End-Stage Renal Disease Care

Nearly six years after Medicare Advantage opened up to people with end-stage renal disease, enrollment has climbed to nearly 280,000 beneficiaries, more than half of all Medicare beneficiaries with ESRD, and almost double what CMS originally projected. ATI Advisory's analysis of six years of Medicare data shows Medicare Advantage has become the primary way ESRD care gets paid for. Nephrologists, dialysis providers, and MA organizations are now negotiating payment rates, building provider networks, and navigating utilization management for a population that used to be financed almost entirely through fee-for-service.
Read More Read More
See more Insights
Share
LinkedIn / /